Table I Index
Table of Contents
Table I - 49 Marion Incidence Rate1 by Primary Site and Sex: Cases Diagnosed in 1996, Indiana |
||||||
Primary Site |
Total |
Males | Females | |||
Number | Rate | Number | Rate | Number | Rate | |
All sites | 3,555 | 403.7 | 1,748 | 474.4 | 1,807 | 354.6 |
Oral cavity and pharynx | 105 | 12.3 | 72 | 19.7 | 33 | 6.0 |
Lip | 7 | 0.8** | 5 | 1.3** | * | # |
Tongue | 20 | 2.4 | 13 | 3.4** | 7 | 1.4** |
Major salivary glands | * | # | * | # | * | # |
Floor of mouth | 10 | 1.1** | 6 | 1.6** | * | # |
Gum and other mouth | 28 | 3.2 | 20 | 5.5 | 8 | 1.3** |
Nasopharynx | * | # | * | # | * | # |
Tonsil | 17 | 2.2** | 12 | 3.5** | 5 | 1.0** |
Oropharynx | * | # | * | # | * | # |
Hypopharynx | 7 | 0.9** | 6 | 1.7** | * | # |
Pharynx and other oral cavity | 6 | 0.7** | * | # | * | # |
Digestive system | 638 | 70.8 | 330 | 90.8 | 308 | 54.4 |
Esophagus | 42 | 5.0 | 35 | 9.8 | 7 | 1.3** |
Stomach | 44 | 4.6 | 28 | 7.6 | 16 | 2.5** |
Small intestine | 11 | 1.3** | * | # | 7 | 1.3** |
Colon excluding rectum | 298 | 32.3 | 132 | 36.1 | 166 | 28.7 |
Rectum and rectosigmoid | 91 | 10.3 | 55 | 14.9 | 36 | 6.8 |
Anus, anal canal, and anorectum | 10 | 1.1** | * | # | 8 | 1.5** |
Liver and intrahepatic bile duct | 33 | 3.9 | 22 | 6.2 | 11 | 2.2** |
Gallbladder | 7 | 0.8** | * | # | 5 | 0.8** |
Other biliary | 13 | 1.4** | 9 | 2.4** | * | # |
Pancreas | 80 | 9.2 | 39 | 11.0 | 41 | 7.5 |
Retroperitoneum | * | # | * | # | * | # |
Peritoneum | 7 | 0.7** | * | # | 6 | 1.0** |
Other digestive organs | * | # | * | # | * | # |
Respiratory system | 735 | 85.7 | 431 | 118.8 | 304 | 61.9 |
Nasal cavity, ear, and sinuses | * | # | * | # | * | # |
Larynx | 44 | 5.3 | 33 | 9.0 | 11 | 2.5** |
Lung and bronchus | 686 | 79.9 | 395 | 109.1 | 291 | 59.1 |
Trachea, pleura, and other respiratory organs | * | # | * | # | * | # |
Bones and joints | 8 | 1.0** | * | # | * | # |
Soft tissue (including heart) | 18 | 2.2** | 12 | 3.0** | 6 | 1.6** |
Skin (excluding basal and squamous) | 101 | 10.8 | 58 | 14.0 | 43 | 8.7 |
Melanoma of the skin | 80 | 8.7 | 45 | 11.4 | 35 | 6.9 |
Other non-epithelial skin cancers | 21 | 2.1 | 13 | 2.6** | 8 | 1.8** |
Breast | 564 | 63.6 | * | # | 563 | 113.5 |
Female genital system | 237 | 26.9 | -- | -- | 237 | 48.2 |
Cervix uteri | 43 | 4.6 | -- | -- | 43 | 8.4 |
Corpus uteri | 102 | 12.0 | -- | -- | 102 | 21.4 |
Uterus, NOS | 8 | 0.9** | -- | -- | 8 | 1.7** |
Ovary | 68 | 7.7 | -- | -- | 68 | 13.8 |
Vagina | * | # | -- | -- | * | # |
Vulva | 13 | 1.4** | -- | -- | 13 | 2.4** |
Other female genital organs | * | # | -- | -- | * | # |
Male genital system | 412 | 48.2 | 412 | 113.4 | -- | -- |
Prostate gland | 379 | 44.8 | 379 | 106.3 | -- | -- |
Testis | 28 | 2.8 | 28 | 5.8 | -- | -- |
Penis | * | # | * | # | -- | -- |
Other male genital organs | * | # | * | # | -- | -- |
Urinary system | 268 | 30.1 | 188 | 50.8 | 80 | 15.2 |
Urinary bladder | 155 | 17.1 | 113 | 30.8 | 42 | 7.7 |
Kidney and renal pelvis | 110 | 12.7 | 73 | 19.5 | 37 | 7.4 |
Ureter | * | # | * | # | * | # |
Other urinary organs | * | # | * | # | * | # |
Eye and orbit | 8 | 0.9** | * | # | * | # |
Brain and other nervous system | 37 | 4.6 | 22 | 5.6 | 15 | 3.6** |
Brain | 32 | 4.0 | 19 | 4.9** | 13 | 3.2** |
Other nervous system | 5 | 0.6** | * | # | * | # |
Endocrine system | 57 | 6.3 | 21 | 5.5 | 36 | 7.1 |
Thyroid gland | 50 | 5.4 | 18 | 4.5** | 32 | 6.2 |
Other endocrine (including thymus) | 7 | 1.0** | * | # | * | # |
Lymphoma | 162 | 17.8 | 94 | 23.4 | 68 | 13.4 |
Hodgkins disease | 20 | 2.0 | 11 | 2.3** | 9 | 1.6** |
Non-Hodgkins lymphoma | 142 | 15.8 | 83 | 21.2 | 59 | 11.8 |
Multiple myeloma | 40 | 4.3 | 21 | 5.6 | 19 | 3.4** |
Leukemia | 67 | 7.6 | 35 | 9.6 | 32 | 6.2 |
Acute lymphocytic | 9 | 1.2** | * | # | 7 | 1.7** |
Chronic lymphocytic | 15 | 1.5** | 10 | 2.5** | 5 | 0.7** |
Acute myeloid | 29 | 3.1 | 16 | 4.5** | 13 | 2.3** |
Chronic myeloid | 8 | 0.9** | * | # | * | # |
Other leukemias | 6 | 0.8** | * | # | * | # |
Other, ill-defined and unknown sites | 98 | 10.6 | 43 | 11.7 | 55 | 9.6 |
1 Per 100,000; Age-adjusted, 1970 U.S. Standard Million. Excludes in situ cancers except bladder, and also excludes basal and squamous cell carcinomas of the skin. * Fewer than 5 cases, number suppressed to protect confidentiality. ** Rates based on fewer than twenty cases are unstable. # Rate cannot be calculated. _______________________________________________________________ Source: Indiana State Department of Health - Indiana State Cancer Registry and the Epidemiology Resource Center, Data Analysis Team, January 2001 |